2020 has become the year of COVID-19, with this particular virus being the topic of discussion everywhere we go. Countries around the world are trying to implement practices to prevent the spread of the virus, but undoubtedly people will still become infected. That in mind, we need to be informed about who is currently infected, through the use of diagnostic tests, and who has been infected, through the use of antibody tests. In order to do that, healthcare professionals have the option of 67 different tests, approved for emergency use authorization by the FDA. With that many tests available, it can be difficult to determine what each test does, how these tests work, and which tests work for which patients. In this paper, we will discuss diagnostic tests and antibody tests, along with some of the technology used to process those tests, including RT-PCR, LFIA, ELISA, and CRISPR.

Read entire article COVID-19 Testing051120